BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carmona P, Mendez N, Ili CG, Brebi P. The Role of Clock Genes in Fibrinolysis Regulation: Circadian Disturbance and Its Effect on Fibrinolytic Activity. Front Physiol 2020;11:129. [PMID: 32231582 DOI: 10.3389/fphys.2020.00129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wrzeszcz K, Słomka A, Zarychta E, Rhone P, Ruszkowska-Ciastek B. Tissue Plasminogen Activator as a Possible Indicator of Breast Cancer Relapse: A Preliminary, Prospective Study. J Clin Med 2022;11:2398. [PMID: 35566525 DOI: 10.3390/jcm11092398] [Reference Citation Analysis]
2 Chen W, Jiang L, Hu Y, Fang G, Yang B, Li J, Liang N, Wu L, Hussain Z. Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: A review. J Control Release 2021;340:342-60. [PMID: 34695522 DOI: 10.1016/j.jconrel.2021.10.020] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Egstrand S, Mace ML, Olgaard K, Lewin E. The Vascular Circadian Clock in Chronic Kidney Disease. Cells 2021;10:1769. [PMID: 34359937 DOI: 10.3390/cells10071769] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Man AWC, Li H, Xia N. Circadian Rhythm: Potential Therapeutic Target for Atherosclerosis and Thrombosis. Int J Mol Sci 2021;22:E676. [PMID: 33445491 DOI: 10.3390/ijms22020676] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
5 Almalki WH, Alghamdi S, Alzahrani A, Zhang W. Emerging paradigms in treating cerebral infarction with nanotheranostics: opportunities and clinical challenges. Drug Discov Today 2021;26:826-35. [PMID: 33383212 DOI: 10.1016/j.drudis.2020.12.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]